Nutrien Ltd. (NYSE:NTR) Shares Bought by Mraz Amerine & Associates Inc.

Mraz Amerine & Associates Inc. increased its holdings in Nutrien Ltd. (NYSE:NTR) by 11.9% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,949 shares of the company’s stock after acquiring an additional 2,441 shares during the quarter. Mraz Amerine & Associates Inc.’s holdings in Nutrien were worth $1,103,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Manning & Napier Advisors LLC acquired a new stake in shares of Nutrien in the 2nd quarter valued at about $2,639,000. Cardinal Capital Management Inc. grew its position in shares of Nutrien by 4.3% in the 3rd quarter. Cardinal Capital Management Inc. now owns 564,078 shares of the company’s stock worth $27,139,000 after acquiring an additional 23,117 shares in the last quarter. SG Americas Securities LLC increased its holdings in shares of Nutrien by 370.1% in the 1st quarter. SG Americas Securities LLC now owns 58,041 shares of the company’s stock valued at $3,152,000 after acquiring an additional 45,695 shares during the last quarter. Royal Fund Management LLC increased its holdings in shares of Nutrien by 88.6% in the 3rd quarter. Royal Fund Management LLC now owns 30,722 shares of the company’s stock valued at $1,477,000 after acquiring an additional 14,434 shares during the last quarter. Finally, BNP Paribas acquired a new stake in shares of Nutrien during the 1st quarter valued at approximately $1,146,000. Institutional investors own 63.10% of the company’s stock.

Nutrien Price Performance

Shares of Nutrien stock opened at $47.82 on Friday. Nutrien Ltd. has a 52 week low of $44.65 and a 52 week high of $60.87. The company has a current ratio of 1.26, a quick ratio of 0.82 and a debt-to-equity ratio of 0.37. The stock has a market cap of $23.66 billion, a PE ratio of 27.96, a price-to-earnings-growth ratio of 1.56 and a beta of 0.82. The company’s 50-day moving average price is $47.74 and its two-hundred day moving average price is $51.00.

Nutrien (NYSE:NTR) last released its earnings results on Wednesday, August 7th. The company reported $2.34 EPS for the quarter, beating the consensus estimate of $2.19 by $0.15. The business had revenue of $10.16 billion during the quarter, compared to analyst estimates of $10.82 billion. Nutrien had a net margin of 2.97% and a return on equity of 6.91%. The business’s quarterly revenue was down 12.9% on a year-over-year basis. During the same period in the prior year, the business earned $2.53 earnings per share. As a group, sell-side analysts anticipate that Nutrien Ltd. will post 3.85 EPS for the current fiscal year.

Nutrien Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 18th. Stockholders of record on Friday, September 27th were given a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 4.52%. The ex-dividend date of this dividend was Friday, September 27th. Nutrien’s dividend payout ratio (DPR) is presently 126.32%.

Analyst Ratings Changes

Several analysts have weighed in on NTR shares. BMO Capital Markets lowered their target price on shares of Nutrien from $80.00 to $75.00 and set an “outperform” rating for the company in a research note on Friday, August 9th. TD Securities decreased their target price on Nutrien from $69.00 to $67.00 and set a “buy” rating for the company in a research note on Thursday, August 1st. Mizuho dropped their price target on Nutrien from $55.00 to $52.00 and set a “neutral” rating on the stock in a research report on Thursday, August 8th. Hsbc Global Res lowered Nutrien from a “hold” rating to a “moderate sell” rating in a research report on Friday, August 2nd. Finally, UBS Group lowered Nutrien from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $66.00 to $51.00 in a research report on Thursday, October 10th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $60.67.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.